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- 3  -I.  THE DISEASE 
In  the  Spring  of  1985,  a  cow  on  a  Kent  farm  became  the first  vi~ctim of 
"bovine spongifor. encephalopathy"  (BSE).  It was  more  than  a  year  later that 
veterinarians  identified the disease as  a  spongiform  encephalopathy,  something 
akin  to scrapie  in sheep.  The  Ministry of Agriculture  of the  United  Kingdom 
made  the  disease  notifiable  in  1988.  Farmers  were  then  legally bound  to 
report all cases.  BSE  has  been  reported  throughout  Great  Britain  but  in 
greater concentration  in  the  southern half of England. 
A few  cases  have  been  identified in Northern  Ireland,  the Republic of  Ireland 
and  the Channel  Islands  and  recently one  case  in Switzerland.  In  the rest of 
the world,  two  cases  have  been  confirmed  in animals  exported  in 1985  f~om the 
UK  to oman.  The  International Office of Epizootics  <based  in Paris)  recorded 
a  total  number  of  18,920  confirmed  cases of cattle affected by  BSE  as  at 12 
October  1990.  Some  veterinarians suggest  that cases exist in other countries, 
where  some  of the  cattle - which  are  destroyed because  they are thought  to 
have  rabies  - might  conceivably have  had  BSE  instead.  The  early  symptoms  of 
rabies  include  weakness  and  general disability  followed  by  paralysis  in the 
hind quarters,  causing very obvious  staggering ...  1 
The  disease is characterised by  a  degeneration of  the central  nervous  system 
caused by  an  "unconventional agent"  (neither virus nor  bacterium).  ·  Different 
views  on  the  type of life-form of these agents have  been  proposed: 
- tiny fila.entous virus:  (H.  Diringer -Robert Koch  Institute, Berlin); 
- virino:  tiny piece of  nucleic  acid  that  hijacks  some  of  the hosts' 
protein  (A.  Dickinson  Institute  of  Animal  Health 
Neuropathogenesis  Unit,  Edinburgh); 
- prion:  'protein that could replicate without  having  a nucleic acid 
(S.  Prusiner- University of California,  San  Francisco,  USA),  or 
is so  small  that it cannot  be  detected to date. 
This  agent 
is  transmissible; 
is characterised by  a  long  incubation period; 
appears  not  to  induce  an  immune  response  (does  not  behave  like an 
antigen); 
is  very  resistant  to  chemical  or  physical  disinfection  and  high 
temperatures  which  remove  bacteria  and  viruses:  also withstands  doses  of 
irradiation and  ultra-violet  light that are normally used  in sterilisation; 
is  identified through  its effect on  brain tissue which  degenerates  to give 
a  spongy  appearance;  exhibits  a  reactive  astrocytosis  of neurons  and 
neuronal  vacuolation. 
Variants of this agent  have  been  found  to  be  responsible  for  disease  to 
several animal  species  and  to man: 
- Creutzfeldt-Jakob Disease  (CJD),  Kuru  and  Gerstmann-StraUssler Syndrome  to 
man, 
- Scrapie  to sheep  and  goats, 
- Chronic  Wasting  Disease  to deer and  antelopes, 
- Transmissible Mink  Encephalopathy  to minks,  and 
- Bovine  Spongiform  Encephalopathy  to cattle. 
- 4  -Some  of  these diseases  have  been  known  for  hundreds  of  years  (scrapie has 
been  endemic  in  the  UK  since  1732),  while others have  only recently been 
diagnosed. 
Many  different strains of this agent exist.  Scrapie,  for  instance,  has  over 
20,  each  having  a  characteristic incubation period and  lesion type/location. 
When  scrapie is  transferred to another  species  (e.g.  in  laboratory  mice),  the 
dominant  strain  may  change.  This  ability to  adapt  suggests  that  the agent 
does  contain some  genetic information. 
I I.  CLINICAL  SICNS 
In  the early stages of BSE  - as  in the  case of  scrapie  - the symptoms  are 
anxiety,  fear,  increased sensitivity,  in some  cases  high aggressiveness  and 
later,  behavioural  gait  and  postural  abnormalities,  reduced  milk  yield, 
slipping  and  falling  followed  by  recumbency  and  death  1-6 months  later. 2 
Cattle between  3 and  11  years  old are  susceptible  to  the disease  with most 
cases affected between  3 and  5 years  old. 
I I I.  OIACNOSIS 
BSE  can only be  confirmed  in POST  MORTEM  examination.  At  present,  there  is no 
laboratory test for  the diagnosis of the disease  in live animals. 
There  is no  evidence of any  abnormality  in the meat  of  infected  animals.  The 
infectious agent  is  found  in the central nervous  system  and  lymphoid  organs. 
The  brains of  infected  animals  have  a  characteristic  spongy  look  <brain 
vacuolation).  Scrapie-associated fibrils  show  up  by  electron microscopy  on 
nervous  tissue extract. 
Examination.  of  infected  brains  fails  to  reveal  any  conventional  micro-
organisms  such  as  bacteria or viruses. 
Dissolving the  nervous  tissue with a  protein-dissolving enzyme  leaves  twisted 
filaments  ('fibrils').  The  fibrils can  be  infectious,  whereas  pure  natural 
protein is  not.  Research  has  yet  to discover  the  infectious component  of  .1e 
fibrils.  It is not clear whether  the  modified  protein is capable of directing 
its own  replication and  modification,  or whether  small  quantities of genetic 
material  from  the agent  exist to take over and  direct brain cell function. 
IY.  TRANSIIISSION 
All  conclusions on  transmission  of  the  agent  are  based  on  circumstantial 
evidence using epidemiology or infP.rreu  f~om laboratory experiments. 
Scrapie  in  sheep  can  be  transmitted from  ewe  to  lamb  (epigenic  transmission-
without  implicating  transmission  through  germ  cells)  and  between  sheep  through 
ingestion of highly  infectious placenta after birth  <horizontal  transmission). 
It is  therefore endemic  and  difficult  to eradicate.  In  the other species 
(humans,  mink,  mice),  the  corresponding disease  is not  normally  spread  from 
one  infected individual  to another and  the  disease  is  said  to  occur  in a 
- 5  -"dead-end"  host.  The  only  known  cases of transmission of Creutzfeldt-Jakob 
Disease  (CJD)  from  man  to man  have  been  by  cornea  grafting,  application of 
deep  brain electrodes or by  surgical  instruments,  or by  injection of pituitary 
extracted products  (HGH,  FSH).  The  spread of  Kuru  in  the  Fore  tribe of New 
Guinea  has  been  attributed to the ceremonial  handling  of ingestion of infected 
human  brains. 
There  appears  to be  a  genetic predisposition to these diseases.  For  instance, 
it  has  been  established  that  susceptibility  to  scrapie  is  influenced by 
genetic factors,  and  a  gene  which  controls  the onset of  the disease  has  been 
found  in  sheep.  While  this offers  the  possibility of introducing resistance 
into flocks,  it would  not  prevent  sheep  becoming  infected. 
In  cattle there  is  to date no  evidence of vertical  or horizontal  transmission 
of the  BSE  agent.  The  following  assumptions  could  thus  be  made:  if cows  are 
dead-end  hosts,  the disease should die out  when  all infected animals  have  been 
slaughtered;  if BSE  is  transmitted  to the  calves of infected animals,  the 
number  of  cases  will  continue  to  increase for  several more  years  as  these 
animals  succumb  and  are destroyed;  if the disease is transmitted from  cow  to 
cow,  the epidemic  will ease off  slightly,  as  the  first  batch  of infected 
animals  is  slaughtered and  then will  soar again,  as  the  disease begins  to 
affect their contacts. 1  The  transmissibility  of BSE  to humans  has  not  been 
proven  and,  so  far.  BSE  is  not  considered as  a  zoonosis.  Nevertheless, 
studies are taking place  to further  investigate this aspect. 
Transmission  studies are a  vital aspect of research  into BSE.  The  experiments 
on  animals  are designed  to show  which  species  can  contract  the disease and 
how.  The  important  point of these experiments  is to  find out  more  about  the 
species barrier.  When  one  of these agents  crosses  from  its natural host  into 
another species,  it usually  meets  some  resistance,  identifiable  by  a  longer 
than  normal  incubation period.  Once  it has  crossed species however,  the  agent 
meets  less resistance  in other  individuals of those  species and  the  incubation 
period becomes  fixed  for  the  new  host.  These  experiments  should  show  how 
"high"  the barrier is  in  different  species.  This  would  be  important  in 
assessing  the risk of a  particular species  succumbing  to BSE.  1 
Epidemiological  evidence  points  strongly  to an  infectious agent  in protein 
concentrates  containing suspect meat  and  bone  meal  as  being a  possible cause 
of  the  outbreak of BSE  in the  UK.  It was  assumed  that  the source of infection 
was  ___ scrapie  from  infected  sheep  tissues  used  in  rendering  processes3 • 
Ac(  L·ding  to  the  report  of the  Working  Party on  BSE  - Oxford,  February  1989 
(the "Southwood  Report"),  a  modification  in the  technique  of making  meat  and 
bone  meal  could have  been  responsible  for  the  transmission of the  infecting 
agent.  Among  the waste  products  of slaughterhouses  - used  as  source material 
for meat  and  bone  meal  - are remains  of sheep  suffering from  scrapie.  A new 
technique,  using a  lower  temperature  in order to  improve  the  nutritive value 
of the  end  product,  has  probably  allowed  the  pathogen  of scrapie to infect 
cattle through  animal  feed.  This  assumption  is  further  developed  in  the 
following  chapter. 
Despite  the  great  resemblance  of  the  pathogens  responsible  for BSE  and 
scrapie,  certain scientists,  nonetheless,  believe  that  BSE  is  not  simply 
sc:r,apie  which  has  crossed  into cows.  but  a  natural encephalopathy of cows  (not 
transmitted  from  sheep),  which  was  so  rare  in  the  past  that  no  one  had 
recognised  it.  Should  this be  the case,  it would  then be  highly probable  that 
the disease exists  in other countries  too ...  1 
- 6  -Y.  FACirJRS RELATING TO  ANIKAL  FEEO 
Irrespective of the exact origin of  BSE,  the  key  to  its sudden  outbreak  in 
the  UK  has  been  attributed to  factors relating to animal  feed,  namely  a)  an 
increase  in  infected  material  rendered  and  b)  changes  in  processing 
techniques  in  the  rendering  industry3 ,  which  may  have  reduced  process 
severity,  thus  allowing •ore of any  infectious agent  to survive.  The  former 
relates  to  an  increase  in the number  of sheep  in  the  UK  in the  late 1970s  and 
early 1980s,  i.e.  to an  increase  in the  incidence of  scrapie and  quantity of 
infected sheep  tissues used  in rendering processes.  The  latter relates  to the 
fact  that,  in the  late 70s,  rendering plants  in the  UK  changed  processing 
techniques.  Instead  of  processing  animal  waste  and  tissues  at  high 
temperatures,  they  adopted  a  system  of  continuous  processing  at  lower 
temperatures.  Most  firms  also abandoned  the use  of solvents  (such as  benzene, 
hexane  and  trichloroethylene)  - which  are considered as  having  a  sterilisation 
effect on  these agents  - to remove  excess  fat  from  the protein.  It is worth 
noting that one  firm  of renderers  that still uses  the  solvent  treatment  is in 
Scotland and  Scotland has  had  a very  small  number  of BSE  cases1 •  Perhaps  more 
significant was  the  loss  of  a  final  heating  stage,  involving  very high 
temperatures,  which  is believed to be  crucial  in killing the  scrapie agent. 
Once  the  infection  is  present  in  feed  concentrates,  the  large production 
capacity of  modern  rendering  factories can  spread it  through  the extensive 
distribution network  of the  feed  compounders.  The  geographical distribution 
of BSE  confirmed  cases  in Great  Britain (more  in the South  than  in the North) 
has  been  related by  the  UK  central veterinary  laboratory to  the extent  to 
which  feed  compounders  use  meat  and  bone  meal  and  the severity of  the process 
used  by  the  rendering  factory.  In  July 1988,  a  ban  on  feeding  ruminant 
protein to ruminants  was  introduced  in the United  Kingdom.  However,  meat  and 
bone  meal  produced  in that country will still contain scrapie,  since  infected 
sheep  are still rendered.  Depending  on  the  effectiveness of  the  July 1988 
Government  ban  on  feeding  ruminant  protein to ruminants  and  the February  1990 
voluntary ban  by  the  UK  industry on  the use  of specific offals,  BSE  •ay still 
be  present.  Such  meal  was,  at first,  banned  for  feeding  to ruminants  in the 
UK,  but allowed  for pigs  and  poultry,  as  well  as  for export.  This  practice 
was  viewed  as  unlikely to lead  to further human  exposure,  since both pigs  and 
poultry are killed for  human  consumption  after a  few  months  (in comparison 
with  the  long  latency  period  of  the  disease).  Nevertheless,  based on 
experience with sheep,  there may  be  initial signs of infection  (primarily the 
lympho-reticular system)  before  the agent  later spreads  to the central nervous 
system.  The  possibility of small  amounts  of the  BSE  agent  entering the  human 
food  chain  cannot,  therefore,  be  excluded,  if pigs or poultry were  to become 
infected.  4  Thus,  it is not  surprising that,  in  the  summer  of 1990,  the  UK 
Government  - seemingly  as  a precautionary  measure  - extended  its ban  on  the 
feeding of specified bovine offals,  i.e.  the spleen,  thymus,  brains,  tonsils, 
spinal and  intestines of cattle,  to pigs  and  poultry.  However  other ruminant 
material continues  to be  a  legally  acceptable  ingredient  in pig  and  poultry 
rations  in the  UK. 
The  risks  are obviously  higher  for other countries,  who  import  meat  and  bone 
meal  processed  in  the  UK  from  ruminant  tissues  (probably)  infected with 
scrapie.  The  aforementioned  ban  affecting  the  UK  market  aggravates  the 
pressure on  the  stocks of  (probably)  scrapie-infected compound  feedstuff and 
increases renderers'  temptation  to export. 
- 7  -Current  UK  regulations  require renderers  to use  conditions which  are effective 
for  SALMONELLA  bacteria,  but which  are  ineffective against  viruses.  Hospital 
autoclaving  procedures  to  inactivate  scrapie  have  been  defined  in  ~he UK: 
134°C  under  pressure for  18  minutes 4 •  The  effectiveness of  this coadition 
seems  to be  confirmed  by  the  findings  of research carried out  by 
Dr.  o.  RIEDINGER,  University  of  Hohenheim,  Germany  (see annex),  but  the 
effectiveness of rendering processes  for  sa.e  objective  has  not  yet been 
adequately studied.  The  industry believes  that factories  cannot  reproduce  the 
same  environment  as  surgical autoclaving.  Thus,  it is not  currently possible 
to define  the  process  conditions  necessary  for complete  sterilisation of meat 
and  bone  meal. 
YI.  ACTION  RECOIIIIENIJEI)  BY  THE  INTERNATION.«  OFFICE  OF  EPIZ(}(}TICS  FOR 
COUNTRIES 6ISHINC trJ II/PORT CA1TL£ AND  CA1TL£ PRODUCTS 
Underneath  is  an  extract  from  a  document  adopted  by  the  International 
Committee  of  the  'Office  International  des  Epizooties'  on  23  July 1990 
relative to this matter: 
"Determine  answers  to the  following  questions  in the country of 
origin : 
- Is  BSE  notifiable ? 
- Does  BSE  or/and scrapie exist or has  it existed in  the past and 
if so at what  prevalence and  incidence? 
- Is  there a  significant sheep  population? 
- Are  ruminant  carcasses  processed  for  inclusion  in ruminant 
rations? 
- Is ruminant  derived meat  and  bone  meal  fed  to cattle  and  what 
is the  inclusion rate? 
From  the  answers  provided.  an  assessment  of  the  actual  or 
potential occurrence of BSE  and  associated  risks can  be  made  and 
appropriate  import  conditions considered,  if necessary. 
Imports  from  countries with BSE: 
- Live  cattle:  Based  on  the available epidemiological  evidence 
concerning  the origin  of  the  disease  and  on  the  known  low 
attack rate  - provided  that  in an  affected country measures  are 
taken  to ban  the  feeding  of  ruminant  protein  to ruminants,  the 
disease is  notifiable and  that affected cattle are slaughtered 
and  destroyed  - it is highly unlikely that animals  exported  from 
that country  will develop  the disease.  However,  should a  case 
occur  in this way  in an  importing country  there is  no  evidence 
to suggest  that this would  necessarily lead  to the establishment 
of the disease. 
- 8  -Cattle  products:  Scientific  studies  in  naturally  occurring 
scrapie of  sheep  indicate there  is no  detectable infectivity in 
muscle,  udder,  colostrum or milk  (and  thus  products  derived  from 
these)  in  either  pre-clinical  or  even  clinically  affected 
animals.  By  extrapolation: 
Meat  and  milk  derived  from  cattle  in countries  in which  BSE 
is present are not  a  danger  to public health. 
With  regard  to  other  parts  of  the  carcass,  as  a 
precautionary  measure,  every  attempt  should  be  made  to 
prevent  large  quantities  of  lymphatic  and  nervous  tissue 
entering products  intended  for human  consumption." 
YII.  FRENCH SURYEILL4NCE SYSTEH 
The  Ministry of Agriculture's  Directorate-General  for  Food,  in collaboration 
with  the  National  Centre  for Veterinary  and  Food  Research,  the Departmental 
Directorates for Veterinary Services  and  the  Pathological Anatomy  Laboratory 
of  the  National  Veterinary  School  at  Alfort,  have  set up  a  surveillance 
network  to deal with  the  BSE  epidemic. 
The  network  comprises  two  components: 
1.  A clinical early warning  network,  relying  on  the  vigilance of practising 
veterinarians  and  the  Departmental  Directorates for Veterinary Services: 
all suspected cases of BSE  are  reported,  and  the  animals  taken  to the 
National  Centre  for  Veterinary  and  Food  Research's  Bovine  Pathology 
Laboratory  in Lyon  for detailed examination. 
2.  A post-mortem  detection network,  based on  the systematic examination of the 
encephala of  rabies  suspects,  which  are removed  and  forwarded,  following  a 
strict procedure,  to specific laboratories for rabies diagnosis. 5 
After  the  rabies  examinations,  negative  samples  are  forwarded  to  the 
Pathological Anatomy  Laboratory of  the National  Veterinary School  at Alfort 
<Prof.  A.L.  PARODI)  or  the Alfort  Histopathology Laboratory  of the  National 
Centre  for  Veterinary and  Food  Research,  for histopathological examination. 
Samples  from  the Rhone-Alpes  region,  which  pass  through  the Pasteur  Institute 
in Lyon,  are sent directly to the Bovine  Pathology Laboratory  there. 
YI  I I.  Sit'  ISS POLICY 
The  first  occurrence of  BSE  in Switzerland has  caused considerable disquiet. 
The  Federal  Swiss  Veterinary Office started proceedings,  on  14  November  1990, 
to draw  up  measures  for its control,  after the first BSE  case  in Switzerland 
was  detected at the beginning of November  (this was  also the first  case  to be 
officially recorded on  the European  continent). 
- 9  -The  measures  for control  include: 
a)  forbidding  the  use  of  meat  and  bone  meal  in animal  feedstuffs,  which  is 
considered as  the  most  likely cause  of the disease; 
b)  ante-mortem  examination of all bovines  more  than  6 months  old; 
c)  regular control  of 
suspected animals; 
with  the disease. 
the  animals;  quarantine  measures  and  slaughter of 
incineration of  the carcasses  of the  animals  infected 
d)  the exclusion,  as  unsuitable  for  human  consumption,  of  the  brain,  the 
spinal cord,  the  thymus,  the spleen and  the  intestines of more  than  6·month 
old bovines. 
In  addition to the control measures,  and  in view  of the  high-risk  category of 
drugs  based  on  raw  material  from  infected  animals,  the  "lntercantonal 
Pharmaceutical  Board  of Control"  (INTERKANTONALE  KONTROLLSTELLE  FUR  HEILNITTEL 
- IKS)  in  Berne,  asked  pharmaceutical  companies  and  pharmacies  to prove  that 
their preparations,  based  on  extracts of  bovine  organs,  are totally harmless 
to man.  According  to Swiss  law,  authorities and  companies  must,  in order to 
protect public health,  take  all  appropriate  steps  to  ensure  that  no  raw 
material  from  infected animals  is employed  in  the  manufacture  of drugs  for use 
on  humans.  The  IKS  now  intends  to reinforce restrictions  to  this end  and  has 
asked  all  companies  that  have  registered preparations derived  from  animal 
matter with  them  to fill out  a questionnaire by  the end  of December. 
IX.  UNITED KINCIXJK PO.liCY 
In  November  1989,  the  UK  Government  introduced a  ban  on  the use  of specified 
offals for  human  consumption.  In  February  1990,  the  UK  rendering  industry 
agreed  to a  voluntary  ban  on  the  use  of  specified  offals  in rendering 
processes. 
The  UK  BSE  Order  of 1988  prohibits  the  sale,  supply  and  feeding  of rations 
containing ruminant  protein to  ruminants  (cattle,  sheep,  goats  and  deer)  in 
the  UK.  This  ban  does  not  affect  exports.  The  UK  rendering  industry  thus 
makes  available to feed  compounders  meat  and  bone  meal  with  and  without 
ruminant  tissue.  Two  different markets  have  therefore been  developed  in the 
United  Kingdom,  one  for  internal  use,  the  other  for  export.  However, 
following  aforementioned  ban  on  the  sale,  supply  and  feeding  of rations 
containing ruminant  protein to  ruminants,  extended  in  summer  1990  to the 
feeding  of  specified bovine  offals to pigs  and  poultry,  the only outlet left 
for such  meal  is as  fertiliser or for export. 
Heat  and  bone  meal  is of  low  nitrogen  content  and  therefore,  only  has  a 
minimal  fertiliser  value unless  used  as  a  long-term  slow  release product  on 
organic-type systems.  Consequently,  the  potential  for expansion  in this area 
is  minimal  relative  to  the  amount  of  processed  specified offal material 
available.  It is  worth  noting,  as  regards  exports,  that  the  UK  Gove~nment 
actually  banned  the  export  of  specified bovine  offal material  in  the  same 
piece of legislation that bans  its use  in pigs  and  poultry rations. 
- 10  -In  consequence  of these preventive measures,  UK  agriculture is now  faced  with 
a  major  ani•al  waste  disposal  problem.  Over  400,000  tonnes  of specified 
bovine  offals  <unprocessed)  plus all casualty or fallen stock can  no  longer  be 
rendered  "safe"  for  inclusion  in animal  feedingstuffs.  The  main  concern of 
the  UK  authorities  is how  best to dispose of this material  without  creating a 
hazard  to public health. 
At  present,  UK  legislation  provides  for  the  compulsory  slaughter  and 
destruction of carcasses  and  the  compensation of farmers,  for each  cow  which 
is found  to be  suffering from  BSE.  As  a  result,  all eases  are recorded  and  the 
authorities are,  therefore,  in a  position to closely  follow  the  evolution of 
the disease. 
The  latter  can  be  considered as  an  important  preventive .easure,  although  the 
very great  need  for  measures  to  assist scientific  teams  working  to find a 
test that can  detect the  disease  in animals  in its early stages,  should  not  be 
underestimated. 1  Diagnosis  before  slaughter  would  help  to  ensure  that 
infected cattle do  not  enter the  human  food  chain. 
An  important  national  research  programme  on  BSE  is already valued at £2 
million and  a  further £12  million will be  used  during  the  next  3 years.  The 
main  aspects  which  will  be  examined  and  clarifi~d  are  :  epidemiology, 
anatomopathology,  transmissibility,  aspects of molecular  biology and  genetics. 
K.  EEC DECISIONS 
A.  In  order  to  re-establish  the  Common  Market  in  the  beefmeat  sector 
(disrupted  by  unilateral  actions  taken  by  some  Member  States against 
imports  of beefmeat  of UK  origin),  and  to  prevent  the  spread of  BSE  from 
the  UK  to  other  Member  States,  ·the  Council  - acting on  a  Commission 
proposal  which  was  based on  the advice of the Standing Veterinary Committee 
- adopted,  on  6/7 June  1990,  the  following  decision6 : 
"1.  The  UK  will not  export  to other countries: 
(a)  live  cattle  other  than  those  aged  under  6 months  and  bearing a 
proper  identification  (tattoo  or  freeze  brand)  to  guarantee 
compliance  with  this point. 
(b)  live  cattle  which  are  the  offspring  of  cows  in which  BSE  is 
suspected or confirmed. 
The  UK  shall  make  full  use  of  computer  records  to  guarantee 
identification of animals. 
2.  The  UK  may  not  export  from  its territory to other Member  States  fresh 
bovine  meat  unless it is: 
(a)  fresh bone-in bovine  meat  derived  from  bovines  not originating from 
holdings  where  BSE  has  been  confirmed  during  the previous  2 years. 
(b)  fresh boneless  meat  from  which,  during  the cutting process,  obvious 
nervous  and  lymphatic  tissue has  been  removed." 
- 11  -These  are  supplementary  measures  to  those  already  introduced  by  the 
Commission  Decision of 9 April  19907 ,  namely  those  foreseen under  Article 2 
of same  decision i.e. 
"1 .·  The  United  Kingdom  shall not  send  from  its terri  tory to that of other 
Member  States: 
a)  the  following  tissues and  organs  derived  from  bovine  animals  aged 
more  than  six months  at slaughter: 
- brains,  spinal cord,  thymus,  tonsils,  spleen,  intestines. 
b)  the  following  tissues and  organs  derived  from  bovine  animals  for 
uses  other than  human  consumption: 
- tissues and  organs  referred to in point a, 
- placental tissue, 
- cell cultures of bovine  origin, 
- serum  and  foetal calf serum, 
pancreas,  surrenal glands,  testicles, ovaries and  hypophisis, 
- other lymphoid  tissues." 
B.  On  25/26  June  1990,  the Council  decided on  the  implementation  of an  EEC 
veterinary fund.  This  fund  would,  inter alia, participate in the  financing 
of  programmes  aiming  to  prevent  and  reduce,  by  appropriate  control 
measures,  the appearance  of serious  infectious animal  diseases which  pose  a 
threat to human  health  (Council  Decision  No.  90/424/EEC  of 26.06.1990  on 
expenditure  in  the veterinary  field,  OJEC  L 224,  p.  19) 8 •  Obviously  BSE 
also falls within  the  scope  of this decision. 
In  countries where  scrapie  exists  for  example  France,  where  it is 
estimated  that  5-10%  of  sheep  are  infected9  - research  should  be 
intensified to prevent  the  spread of the disease  in bovines.  So  far,  no 
Member  State  has  presented a  proposal  to the  Community  in the  framework  of 
the aforementioned decision. 
The  Commission  has  undertaken  to  elaborate  a  Community-wide  research 
programme  for  BSE.  In  this programme,  the  aspect of the diagnosis of the 
disease in live animals  in its earlv stage and  prior  to the  appearance  of 
clinical  signs,  is  of  a  particular (scientific and  economic)  interest. 
Other  topics  to  be  undertaken  in  the  programme  are:  Epidemiology. 
Molecular  biology,  Rendering  of offals.  etc. 
XI.  CONCLUSIONS 
There  are a  number  of unconventional  infective agents  in man  and  animals  which 
attack the central  nervous  system  and  cause  the  brain's  grey  matter to 
degenerate.  Since  1985,  cattle have  been  suffering from  the bovine  form  of 
this disease  in increasing numbers  in the  UK,  leading  to  a  series  of control 
measures  by  this Member  State and  the  EEC.  Debate  continues,  however,  on  the 
public health implications of BSE. 
- 12  -Despite  the extensive research,  many  questions  still remain  unanswered  with 
respect  to BSE.  They  can  be  grouped  into three main  areas: 
a)  Nature  and  MODUS  OPERANDI  of the  infectious agent:  There  are a  lot of 
views  about  what  BSE  is or isn't.  The  agent  may  be  a  form  of scrapie that 
has  mutated,  either in  sheep  or  cows,  after they  have  eaten contaminated 
food.  If BSE  is a  scrapie that has  crossed  into cows,  then  it  has  already 
made  one  jump  over  the species  barrier.  If BSE  has  always  existed as  a 
natural cattle disease,  then  it is likely to remain  a disease of cattle. 
b)  Conditions  for  inactivation of the agent  and  sterilisation of meat  and  bone 
meal:  These  have  been  defined for hospital autoclaving procedures,  but  not 
for  factory rendering processes. 
c)  Infectivity  and  transmissibility:  Experiments  to  investigate  the 
infectivity and  transmissibility from  cow  to calf,  from  cow  to cow  and  from 
cow  to other species are underway. 
Some  experts see  the absence  of  an  epidemiological  link between  scrapie and 
Creutzfeldt-Jacob Disease  (CJD)  as  indicating that BSE  is unlikely to pose  a 
significant health threat to humans.  However,  the uncertainty reigning  in the 
scientific  field,  and  the  great  number  of  questions  that  still remain 
unanswered,  calls for precaution.  It should  be  recalled in  this context  that 
CJD  is  a devastating disease to mankind,  as  are the other types  of spongiform 
encephalopathy.  It  takes  a  long  time  (even  decades)  to  incubate:  when 
symptoms  finally appear,  the  course of the disease  is catastrophic.  It begins 
with  loss of memory  and  other uncharacteristic behaviour,  progressing  to rapid 
mental  deterioration,  dementia,  incoordination and  involuntary movement  of the 
limbs.  CJD  is fatal and  most  people die within a  few  months 1 •  CJD  has  been 
contracted by  meat-eaters  and  non-meat-eaters all over  the world,  in countries 
where  scrapie is endemic  (e.g.  Japan)  and  in countries where  it has  never been 
recorded  (e.g.  Australia).  The  issues  of the horizontal and/or vertical 
transmission of this unconventional  agent  to animals  and  humans  are uncertain 
and  are  the  subjects  of  current  research,  therefore necessary precaution 
should be  taken until such  issues are fully  investigated. 
The  PRECAUTIONARY  PRINCIPLE  places  an  emphasis  on  anticipating possible 
consequences  before  scientific evidence  is made  available.  Although  policy 
makers  at national  and  EEC  level  are  convinced  they  adopted  appropriate 
policy  measures  on  an  assessment  of  risk  made  from  the best available 
scientific evidence  to date,  there  have  been  calls  for  the precautionary 
principle  to  be  further  applied  in  view  of the uncertainties which  will 
continue  to exist for  some  years  as  research  takes  time  to  produce  its 
results.  Such  an  approach would  attempt  to eliminate  the unguantifiable risk 
of BSE  spreading  to humans  or  animals.  through  the exclusion  of the  use  of 
drugs  derived  from  suspect  animal  matter or of suspect meat  and  bone  meal  in 
animal  feed. 
In  this connection,  the proposal  for  a  Council  Regulation  <EEC)  laying  down 
the veterinary  rules  for  the disposal  and  processing of animal  waste,  for its 
placing on  the market  and  for  the  prevention  of  pathogens  in  feedstuffs 
(COM(89)509  final)  presented by  the Commission  on  17  October  1990  and  which 
received the Parliament's opinion on  13.09.1990,  should be  noted. 10  Article 
3  of  Chapter  II  of  this  proposal  includes  in  the  so-called "HIGH-RISK 
- 13  -MATERIALS"  allowed  to be  processed by  the  rendering  industry in  the  Member 
States 
"c)  animals  which  are killed  either on  the  farm,  or after arrival at the 
processing plant,  in order  to eradicate epizootic diseases: 
d)  animal  waste  originating from  animals  which  show,  during  vete~inary 
inspection  at  slaughter,  clinical  signs  or  evidence  of diseases 
communicable  to humans  and  which  are  for  that  reason,  or  due  to the 
presence of residues,  excluded  from  human  consumption: 
e)  those  parts  of  slaughtered  animals  not  presented for post-•ortem 
inspection,  with  the  exception  of  hides,  skins,  hooves,  feathers, 
wool,  horns  and  siailar products; .....  " 
This  Community  Directive  which  allows  for  rendering  of  these high-risk 
•aterials, which  may  indeed  include SSE-infested  matter,  obviously  does  not 
satisfy the  aforementioned  precautionary  principle and  an  adequate  solution 
should be  sought  to avoid  such  a  risk.  It  should be  noted  in  this respect 
that neither  the  amendments  presented by  the European  Parliament10  nor  the 
revised  Commission  proposal  following  the  EP's  opinion11  take  into 
consideration the difficulty of destroying  the  BSE  agent  in animal  feedstuffs. 
One  of the EP's  amendments  proposed  a  heat  treatment of 121°C  for  100  minutes 
as  a  general  treatment  irrespective of the pathogen  involved.  This  ameadment 
has  not,  however,  been  retained by  the Commission.  The  Council  decided  on  the 
Commission's  amended  proposal  on  27.11.1990. 12 
In  addition  to the  above  regulation,  the  Council  Directive 90/44/EEC  of 22 
January  1990  modifying  Council  Directive 79/373/EEC,  concerning marketing of 
compound  animal  feedstuffs  (OJEC  L 27  of 31.01.1990,  p.  35),  should also be 
re-examined.  For  instance,  it is obvious  that if compound  feedstuffs  produced 
from  scrapie-infected  animal  waste  and  tissues are allowed  to be  marketed  as 
animal  feedstuff  in Member  States  (other  than  the  UK  where  a  local ban 
exists),  an  appropriate  label should,  at least, be  foreseen  to inform  possible 
users of their origin (and  subsequent  usage  risk). 
Until current research programmes  produce  conclusive  results,  it  would  be 
prudent  to  extend  to  the  rest of the Community  the  precautionary measures 
which  are now  applied  in  the  UK  for  the  control  of  BSE.  The  recently 
established common  veterinary fund  should be  fully used  to this end.  However, 
measures  taken  to control BSE  within  the Community  would  be  ineffective tn the 
absence  of  adequate  control  with  regard  to  imports.  Therefore,  the  same 
degree of efficiency should  be sought  to ensure  imports  of  BSE-free  meat  and 
other animal  tissues and  organs,  as  well  as  imports  of quality meat  and  bone 
meal  for  animal  feed.  The  biggest  problem  remains,  nonetheless,  the 
identification and  elimination of drugs  derived  from  suspect animal  matter. 
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